Search Results - "Vartanov, Alexander R"

Refine Results
  1. 1
  2. 2

    Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19 by Hundal, Jasmin, Vartanov, Alexander R, Huh, Kang, Ballesteros, Enrique, Forbes, Victoria

    Published in Curēus (Palo Alto, CA) (26-02-2022)
    “…The coronavirus disease 2019 (COVID-19) global pandemic has put an unprecedented strain on cancer care. The initial months were marred by fears of…”
    Get full text
    Journal Article
  3. 3

    Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia by Velez, Nicole F, Karia, Pritesh S, Vartanov, Alexander R, Davids, Matthew S, Brown, Jennifer R, Schmults, Chrysalyne D

    Published in JAMA dermatology (Chicago, Ill.) (01-03-2014)
    “…Although it has been well established that patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing skin cancer, few studies have…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib by Vartanov, Alexander R., Matos, Tiago R, McWilliams, Emily M., Gadi, Deepti, Rao, Deepak, Kasar, Siddha, Lampson, Benjamin L., Fernandes, Stacey M., Ritz, Jerome, Brown, Jennifer R.

    Published in Blood (29-11-2018)
    “…Introduction Phosphatidylinositol-3-kinase (PI3K) inhibition has emerged as a novel targeted mechanism for achieving durable remission in CLL in both the…”
    Get full text
    Journal Article
  8. 8

    High Sensitivity NGS Analysis of MRD in CLL Patients Prospectively Treated with Ibrutinib Plus FCR (iFCR) by Vartanov, Alexander R., Fernandes, Stacey M., Nguy, Winnie I, Brander, Danielle M., Tyekucheva, Svitlana, Savell, Alexandra, Jacob, Allison P., Arnason, Jon E., Abramson, Jeremy S., Davids, Matthew S., Brown, Jennifer R.

    Published in Blood (13-11-2019)
    “…Background Studies from the chemoimmunotherapy (CIT) era and more recently with venetoclax have demonstrated the correlation between minimal residual disease…”
    Get full text
    Journal Article
  9. 9

    Imbalance in T Cell Subsets Triggers the Autoimmune Toxicity of PI3K Inhibitors in CLL by Gadi, Deepti, Kasar, Siddha, Griffith, Alec, Chiu, Pui Yan, Tyekucheva, Svitlana, Rai, Vanessa, Vartanov, Alexander R., Fernandes, Stacey M., Pan, Yang, Lederer, James A, Sherry, Barbara, Brown, Jennifer R.

    Published in Blood (13-11-2019)
    “…Idelalisib and duvelisib are FDA approved oral inhibitors of PI3K delta and PI3K delta/gamma, respectively. Previously, we reported a decrease in regulatory T…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Whole Genome Sequencing of Indolent CLL Reveals Novel Structural Rearrangements by Kasar, Siddha, Tiao, Grace, Improgo, Reina, Kiezun, Adam, Sougnez, Carrie, Bahl, Samira, Fernandes, Stacey M., Vartanov, Alexander R., Hoang, Kevin, Gabriel, Stacey, Landau, Dan A., Wu, Catherine J, Lander, Eric, Kim, Haesook T., Getz, Gad, Brown, Jennifer R.

    Published in Blood (06-12-2014)
    “…Several recent next generation sequencing studies have uncovered mutations in key genes that contribute to CLL pathogenesis. Most CLLs with deletions of…”
    Get full text
    Journal Article
  13. 13

    Rearrangement of 14q32 in the Absence of t(14;18) Is Associated with Short Time to First Treatment in Chronic Lymphocytic Leukemia by Davids, Matthew S., Vartanov, Alexander R., Werner, Lillian, Neuberg, Donna, Cin, Paola Dal, Brown, Jennifer R

    Published in Blood (18-11-2011)
    “…Abstract 1438 The hierarchical cytogenetic classification for chronic lymphocytic leukemia (CLL) provides a valuable prognostic framework validated in several…”
    Get full text
    Journal Article
  14. 14

    Prior Treatment with Chemotherapy Is Associated with Poor Outcomes of High Risk Skin Cancers in Patients with Chronic Lymphocytic Leukemia by Davids, Matthew S., Velez, Nicole F., Karia, Pritesh, Guo, Ye, Vartanov, Alexander R., Neel, Victor A., Brown, Jennifer R., Schmults, Chrysalyne D.

    Published in Blood (16-11-2012)
    “…Abstract 3920 The increased incidence of skin cancer in patients with chronic lymphocytic leukemia (CLL) has been well-documented; however, the outcomes for…”
    Get full text
    Journal Article
  15. 15

    Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro by Tesar, Bethany, Chaudhary, Divya, Werner, Lillian, Improgo, Reina, Pochet, Nathalie, Fernandes, Stacey M, Hoang, Kevin, Vartanov, Alexander R., Romero, Donna L., Robinson, Shaughnessy D., Neuberg, Donna S., Westlin, William F., Brown, Jennifer R.

    Published in Blood (15-11-2013)
    “…Recent work in CLL and other lymphoproliferative disorders has established the importance of somatic mutations in the pathogenesis and prognosis of disease…”
    Get full text
    Journal Article
  16. 16

    NF-κB Pathway Mutations Modulate Cell Survival and Ibrutinib Response In Chronic Lymphocytic Leukemia by Improgo, Reina, Tiao, Grace, Kiezun, Adam, Wang, Yaoyu, Werner, Lillian, Sougnez, Carrie, Tesar, Bethany, Fernandes, Stacey M, Vartanov, Alexander R., Hoang, Kevin, Neuberg, Donna S., Getz, Gad, Brown, Jennifer R.

    Published in Blood (15-11-2013)
    “…Constitutive activation of the NF-κB pathway is a critical feature of hematologic malignancies and is associated with increased lymphocyte proliferation and…”
    Get full text
    Journal Article
  17. 17

    Functional Somatic and Germline Variants in the NF-κB Pathway in Chronic Lymphocytic Leukemia by Improgo, Ma. Reina, Kiezun, Adam, Wang, Yaoyu, Werner, Lillian, Stojanov, Petar, Landau, Dan, Sougnez, Carrie, Tesar, Bethany, Fernandes, Stacey M., Vartanov, Alexander R., Lawrence, Michael S., Cibulskis, Kristian, Neuberg, Donna S., Wu, Catherine J., Getz, Gad, Brown, Jennifer R.

    Published in Blood (16-11-2012)
    “…Abstract 560 Nuclear factor kappa B (NF-κB) encompasses a family of transcription factors involved in oncogenic processes including cellular proliferation and…”
    Get full text
    Journal Article
  18. 18

    Somatic and Germline Copy Neutral Loss of Heterozygosity Are Common in Chronic Lymphocytic Leukemia by Hanna, Megan, Tesar, Bethany, Stevenson, Kristen E., Vartanov, Alexander R., Fernandes, Stacey M., Macconaill, Laura, Landau, Dan-Avi, Wu, Catherine J., Neuberg, Donna S., Freedman, Arnold S., Brown, Jennifer R.

    Published in Blood (16-11-2012)
    “…Abstract 4567 Chronic lymphocytic leukemia (CLL) is the most common leukemia of adults, and prognosis is still difficult to predict, although cytogenetic…”
    Get full text
    Journal Article
  19. 19
  20. 20